Longevity Health Holdings Inc.
XAGE · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.28 | -0.20 | 0.70 |
| FCF Yield | -118.39% | -1.59% | -0.96% | -0.44% |
| EV / EBITDA | -0.49 | -28.32 | -54.76 | -181.73 |
| Quality | ||||
| ROIC | 46.51% | 60.22% | 49.75% | 22.34% |
| Gross Margin | 48.70% | 60.10% | 52.87% | 92.99% |
| Cash Conversion Ratio | 1.00 | 0.44 | 0.50 | 0.95 |
| Growth | ||||
| Revenue 3-Year CAGR | -26.89% | 1,016,929.35% | 824,486.14% | 369,082.51% |
| Free Cash Flow Growth | -73.16% | -11.05% | 2.48% | 44.96% |
| Safety | ||||
| Net Debt / EBITDA | 0.33 | 0.65 | 0.17 | -0.50 |
| Interest Coverage | -290.77 | -725.73 | -301.77 | -134.02 |
| Efficiency | ||||
| Inventory Turnover | 0.22 | 0.17 | 0.17 | 0.01 |
| Cash Conversion Cycle | -1,290.94 | -1,467.08 | -1,134.58 | -288,583.71 |